Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Metabolites|July 2, 2020
Metabolic Signatures of Tumor Responses to Doxorubicin Elucidated by Metabolic Profiling in OvoIman W Achkar, Sara Kader, Shaima S Dib, et al.
FEBS Open Bio|January 31, 2025
Pharmacological effects of osimertinib on a chicken chorioallantoic membrane xenograft model with the EGFR exon-19-deleted advanced NSCLC mutationDavid Barthélémy, Arnaud Vigneron, Xavier Rousset, et al.
Cancers|January 8, 2023
The CAM Model-Q&A with ExpertsDagmar Fischer, Georg Fluegen, Paul Garcia, et al.
Cancers|September 9, 2022
Embryonated Chicken Tumor Xenografts Derived from Circulating Tumor Cells as a Relevant Model to Study Metastatic Dissemination: A Proof of ConceptXavier Rousset, Denis Maillet, Emmanuel Grolleau, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2018
Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, ItalyMichele Maio, George Coukos, Soldano Ferrone, et al.
British Journal of Pharmacology|September 26, 2012
Azaindole derivatives are inhibitors of microtubule dynamics, with anti-cancer and anti-angiogenic activitiesRenaud Prudent, Émilie Vassal-Stermann, Chi-Hung Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2007
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosisMai Nguyen, Richard C Marcellus, Anne Roulston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
A phase I study of the pan bcl-2 family inhibitor obatoclax mesylate in patients with advanced hematologic malignanciesAaron D Schimmer, Susan O'Brien, Hagop Kantarjian, et al.
Pageof 3